Evidence map›Paper›PMID 36637203›Full record

ArticleJournal of the National Cancer Institute2023

Advancing rapid cycle research in cancer care delivery: a National Cancer Institute workshop report.

Wynne E Norton, Amy E Kennedy, Brian S Mittman, Gareth Parry, Shobha Srinivasan, Emily Tonorezos, Robin C Vanderpool, Paul B Jacobsen

Open access · hybridAbstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
9.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Global cancer stigma research: a U.S. National Cancer Institute workshop report.Journal of the National Cancer Institute. Monographs · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wynne E NortonDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0002-9895-8078
Amy E KennedyDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0001-9589-5510
Brian S MittmanDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Gareth ParryHealth Equity Research Lab, Cambridge Health Alliance, Cambridge, MA, USA.ORCID 0000-0001-5620-6516
Shobha SrinivasanDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0003-1207-2645
Emily TonorezosDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0002-1185-5210
Robin C VanderpoolDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0001-9995-4485
Paul B JacobsenDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0002-4427-8800
National Cancer Institute · USCambridge Health Alliance · USKaiser Permanente · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generating actionable research findings quickly and efficiently is critical for improving the delivery of cancer-related care and outcomes. To address this issue, the National Cancer Institute convened subject matter experts, researchers, clinicians, and patients for a 2-day virtual meeting in February 2022. The purpose of this meeting was to identify how rapid cycle interventional research methods can be used to generate findings useful in improving routine clinical practice. The meeting yielded an initial conceptualization of rapid cycle interventional research as being comprised of 6 key elements: use of iterative study designs; reliance on proximal primary outcomes; early and continued engagement with community and clinical partners; use of existing data sources to measure primary outcomes; facilitative features of the study setting and context; and consideration of appropriate rigor relative to intended use of findings. The meeting also identified the types of study designs that can be leveraged to conduct rapid cycle interventional research and provided examples of these; considered this approach from the perspective of key partners; described the clinical and data infrastructure, research resources, and key collaborations needed to support this work; identified research topics best addressed using this approach; and considered needed methodological advances. The National Cancer Institute is committed to exploring opportunities to encourage further development and application of this research approach as a means for better promoting improvements in the delivery of cancer-related care.

Indexed as

Delivery of Health CareNeoplasmsHealth Services ResearchHumansNational Cancer Institute (U.S.)Research DesignUnited States

Identifiers

PMID36637203
PMCPMC10165484
OpenAlexW4315927849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.